Total Payments
$18,694
2024 Payments
$3,487
Companies
92
Transactions
935
Medicare Patients
6,870
Medicare Billing
$771,789
Payment Breakdown by Category
Food & Beverage$18,364 (98.2%)
Education$329.83 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,364 | 924 | 98.2% |
| Education | $329.83 | 11 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,333 | 122 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,755 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,338 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $887.01 | 44 | $0 (2024) |
| Incyte Corporation | $862.66 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $846.06 | 76 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $672.01 | 30 | $0 (2023) |
| PFIZER INC. | $597.77 | 38 | $0 (2024) |
| Celgene Corporation | $453.82 | 27 | $0 (2024) |
| Genentech USA, Inc. | $450.32 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,487 | 149 | Merck Sharp & Dohme LLC ($480.71) |
| 2023 | $3,070 | 129 | Merck Sharp & Dohme LLC ($336.74) |
| 2022 | $2,599 | 118 | Merck Sharp & Dohme LLC ($213.17) |
| 2021 | $1,539 | 75 | Janssen Biotech, Inc. ($152.92) |
| 2020 | $1,712 | 88 | Novartis Pharmaceuticals Corporation ($243.99) |
| 2019 | $2,132 | 112 | AstraZeneca Pharmaceuticals LP ($374.17) |
| 2018 | $1,917 | 120 | Novartis Pharmaceuticals Corporation ($478.54) |
| 2017 | $2,237 | 144 | Novartis Pharmaceuticals Corporation ($500.98) |
All Payment Transactions
935 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $31.75 | General |
| Category: Hematology | ||||||
| 12/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Hematology | ||||||
| 12/13/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $2.92 | General |
| Category: Hematology | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.96 | General |
| 12/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: Hematology | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Hematology/Oncology | ||||||
| 11/21/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $1.07 | General |
| Category: Hematology/Oncology | ||||||
| 11/19/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $31.60 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,670 | 3,474 | $525,125 | $152,115 |
| 2022 | 14 | 1,712 | 3,707 | $552,607 | $162,031 |
| 2021 | 16 | 1,714 | 9,354 | $545,685 | $214,378 |
| 2020 | 21 | 1,774 | 26,673 | $574,767 | $243,265 |
Total Patients
6,870
Total Services
43,208
Medicare Billing
$771,789
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 349 | 729 | $251,505 | $73,546 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 249 | $120,765 | $34,544 | 28.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 71 | 71 | $41,961 | $12,386 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 125 | $30,625 | $8,544 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 276 | 752 | $32,336 | $5,692 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 248 | 600 | $7,800 | $5,007 | 64.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 171 | 362 | $11,584 | $3,747 | 32.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 36 | $8,820 | $2,596 | 29.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 131 | $5,109 | $1,553 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,550 | $1,306 | 28.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 50 | 72 | $3,024 | $961.92 | 31.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 78 | 139 | $2,085 | $822.88 | 39.5% |
| 83550 | Iron binding capacity | Office | 2023 | 44 | 60 | $1,200 | $514.20 | 42.9% |
| 83540 | Iron level | Office | 2023 | 44 | 60 | $1,020 | $380.40 | 37.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 11 | 14 | $630.00 | $206.92 | 32.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 17 | 31 | $1,271 | $196.54 | 15.5% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 16 | 30 | $840.00 | $111.60 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 336 | 570 | $196,650 | $59,596 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 184 | 406 | $196,910 | $58,488 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 83 | 83 | $49,053 | $15,433 | 31.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 323 | 942 | $40,506 | $7,210 | 17.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 38 | 51 | $12,495 | $3,907 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 50 | $12,250 | $3,801 | 31.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 34 | $11,730 | $3,570 | 30.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 180 | 330 | $10,560 | $3,442 | 32.6% |
About Dr. George Miranda, MD
Dr. George Miranda, MD is a Hematology & Oncology healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558545038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Miranda, MD has received a total of $18,694 in payments from pharmaceutical and medical device companies, with $3,487 received in 2024. These payments were reported across 935 transactions from 92 companies. The most common payment nature is "Food and Beverage" ($18,364).
As a Medicare-enrolled provider, Miranda has provided services to 6,870 Medicare beneficiaries, totaling 43,208 services with total Medicare billing of $771,789. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Mission Viejo, CA
- Active Since 12/20/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1558545038
Products in Payments
- KEYTRUDA (Biological) $1,658
- OPDIVO (Biological) $665.96
- IMBRUVICA (Drug) $569.43
- IMFINZI (Drug) $513.67
- TASIGNA (Drug) $495.41
- KISQALI (Drug) $488.73
- JAKAFI (Drug) $444.46
- Imbruvica (Drug) $370.70
- DARZALEX (Biological) $342.27
- JADENU (Drug) $322.89
- REBLOZYL (Biological) $312.54
- ADCETRIS (Biological) $290.42
- PROMACTA (Drug) $285.69
- Bavencio (Biological) $260.81
- MEKINIST (Drug) $241.94
- Lenvima (Drug) $241.05
- MONJUVI (Drug) $229.15
- BRUKINSA (Drug) $217.68
- LIBTAYO (Biological) $209.57
- XARELTO (Drug) $193.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mission Viejo
Ming Li, Md, MD
Hematology & Oncology — Payments: $22,556
Hematology & Oncology $22,556
Minch Fong, M.d, M.D
Hematology & Oncology — Payments: $19,803
Hematology & Oncology $19,803
Lloyd Nagasawa, M.d, M.D
Hematology & Oncology — Payments: $8,797
Hematology & Oncology $8,797
Nicholas Burley, Do, DO
Hematology & Oncology — Payments: $1,607
Hematology & Oncology $1,607